Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Geriatrics
Published in: BMC Geriatrics 1/2022

01-12-2022 | Mood Disorders | Research

Associations of walking impairment with visual impairment, depression, and cognitive function in U.S. older adults: NHANES 2013–2014

Authors: Wei Gao, Pengfei Dai, Yuqian Wang, Yurong Zhang

Published in: BMC Geriatrics | Issue 1/2022

Login to get access

Abstract

Background

Walking impairment, a common health problem among older adults, has been linked to poor vision and mental health. This study aimed to investigate the associations of walking impairment with visual impairment, depression, and cognitive function in older adults.

Methods

A total of 1,489 adults aged 60 years and older who had participated in the National Health and Examination Survey (NHANES) 2013–2014 in the United States were included. Multivariate logistic regression models were used to examine the associations of walking impairment with visual impairment, depression, and four subdomains of cognitive function. Sample weights were used to ensure the generalizability of the results.

Results

Among all the participants (median age = 68 years; 53.7% women), 17.5% reported walking impairment. Walking impairment was significantly associated with visual impairment (adjusted odds ratio [aOR] = 2.76; 95% CI: 1.47–5.20) and depression (aOR = 4.66; 95% CI: 3.11–6.99). Walking impairment was only associated with the Digit Symbol Substitution (DSST) subdomain of cognitive function in total participants (aOR = 0.97; 95% CI: 0.95–0.99) and in non-Hispanic white adults (aOR = 0.96; 95% CI: 0.94–0.98). Participants with two or three impairment indicators had a higher OR of walking impairment (aOR = 3.64, 95% CI = 2.46–5.38) than those with 0–1 (reference group) impairment indicator.

Conclusions

Walking impairment was associated with visual impairment, depression, and cognitive impairment in American older adults and also positively associated with the number of impairment indicators. The association between walking impairment and cognitive impairment varied according to race. Evaluations of vision, cognition, and depression should be conducted among older adults with walking impairment, and the needs of older adults should be provided in the evaluations alongside information on the biological aspects of their particular race.
Appendix
Available only for authorised users
Literature
1.
Perlmutter MS, Bhorade A, Gordon M, Hollingsworth HH, Baum MC. Cognitive, visual, auditory, and emotional factors that affect participation in older adults. Am J Occup Ther. 2010;64:570–9.CrossRefPubMed
2.
Manton KG, Corder L, Stallard E. Chronic disability trends in elderly United States populations: 1982–1994. Proc Natl Acad Sci U S A. 1997;94:2593–8.CrossRefPubMedPubMedCentral
3.
Lee IM, Buchner DM. The importance of walking to public health. Med Sci Sports Exerc. 2008;40:S512–8.CrossRefPubMed
4.
5.
Belza B, Walwick J, Shiu-Thornton S, Schwartz S, Taylor M, LoGerfo J. Older adult perspectives on physical activity and exercise: voices from multiple cultures. Prev Chronic Dis. 2004;1:A09.PubMedPubMedCentral
6.
Heesch KC, Burton NW, Brown WJ. Concurrent and prospective associations between physical activity, walking and mental health in older women. J Epidemiol Community Health. 2011;65:807–13.CrossRefPubMed
7.
Landi F, Russo A, Cesari M, Pahor M, Liperoti R, Danese P, et al. Walking one hour or more per day prevented mortality among older persons: results from ilSIRENTE study. Prev Med. 2008;47:422–6.CrossRefPubMed
8.
Torres ER, Sampselle CM, Neighbors HW, Ronis DL, Gretebeck KA. Depressive Symptoms and Walking in African-Americans. Public Health Nurs. 2015;32:381–7.CrossRefPubMed
9.
Weuve J, Kang JH, Manson JE, Breteler MM, Ware JH, Grodstein F. Physical activity, including walking, and cognitive function in older women. JAMA. 2004;292:1454–61.CrossRefPubMed
10.
Paula TP, Viana LV, Neto AT, Leitao CB, Gross JL, Azevedo MJ. Effects of the DASH Diet and Walking on Blood Pressure in Patients With Type 2 Diabetes and Uncontrolled Hypertension: A Randomized Controlled Trial. J Clin Hypertens (Greenwich). 2015;17:895–901.CrossRef
11.
Hawker GA, Croxford R, Bierman AS, Harvey P, Ravi B, Kendzerska T, et al. Osteoarthritis-related difficulty walking and risk for diabetes complications. Osteoarthritis Cartilage. 2017;25:67–75.CrossRefPubMed
12.
Sui SX, Holloway-Kew KL, Hyde NK, Williams LJ, Leach S, Pasco JA. Muscle strength and gait speed rather than lean mass are better indicators for poor cognitive function in older men. Sci Rep. 2020;10:10367.CrossRefPubMedPubMedCentral
13.
Klein BE, Klein R, Knudtson MD, Lee KE. Relationship of measures of frailty to visual function: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2003;101:191–6 (discussion 6-9).PubMedPubMedCentral
14.
Wang Y, Wang J, Liu X, Zhu T. Detecting Depression Through Gait Data: Examining the Contribution of Gait Features in Recognizing Depression. Front Psychiatry. 2021;12:661213.CrossRefPubMedPubMedCentral
15.
Kyrdalen IL, Thingstad P, Sandvik L, Ormstad H. Associations between gait speed and well-known fall risk factors among community-dwelling older adults. Physiother Res Int. 2019;24:e1743.CrossRefPubMed
16.
Bhatia D, Salbach NM, Akinrolie O, Alsbury-Nealy K, Dos Santos RB, Eftekhar P, et al. Outdoor Community Ambulation Interventions to Improve Physical and Mental Health in Older Adults: A Systematic Review and Meta-Analysis. J Aging Phys Act. 2022;1-14. https://​doi.​org/​10.​1123/​japa.​2021-0151. Online ahead of print
17.
Lee PP, Feldman ZW, Ostermann J, Brown DS, Sloan FA. Longitudinal prevalence of major eye diseases. Arch Ophthalmol. 2003;121:1303–10.CrossRefPubMed
18.
Chan T, Friedman DS, Bradley C, Massof R. Estimates of Incidence and Prevalence of Visual Impairment, Low Vision, and Blindness in the United States. JAMA Ophthalmol. 2018;136:12–9.CrossRefPubMed
19.
Swenor BK, Bandeen-Roche K, Muñoz B, West SK. Does walking speed mediate the association between visual impairment and self-report of mobility disability? The Salisbury Eye Evaluation Study. J Am Geriatr Soc. 2014;62:1540–5.CrossRefPubMedPubMedCentral
20.
Nesemann JM, Kandel RP, Byanju R, Poudyal B, Bhandari G, Bhandari S, et al. Association of visual impairment with disability: a population-based study. Eye (Lond). 2022;36:540–6.CrossRef
21.
Jang BN, Lee HJ, Joo JH, Park EC, Jang SI. Association between health behaviours and depression: findings from a national cross-sectional study in South Korea. BMC Psychiatry. 2020;20:238.CrossRefPubMedPubMedCentral
22.
Reynolds SL, Haley WE, Kozlenko N. The impact of depressive symptoms and chronic diseases on active life expectancy in older Americans. Am J Geriatr Psychiatry. 2008;16:425–32.CrossRefPubMed
23.
Langa KM, Larson EB, Crimmins EM, Faul JD, Levine DA, Kabeto MU, et al. A Comparison of the Prevalence of Dementia in the United States in 2000 and 2012. JAMA Intern Med. 2017;177:51–8.CrossRefPubMedPubMedCentral
24.
Langoni CDS, Resende TL, Barcellos AB, Cecchele B, Knob MS, Silva TDN, et al. Effect of Exercise on Cognition, Conditioning, Muscle Endurance, and Balance in Older Adults With Mild Cognitive Impairment: A Randomized Controlled Trial. J Geriatr Phys Ther. 2019;42:E15–22.CrossRefPubMed
25.
Hackett RA, Davies-Kershaw H, Cadar D, Orrell M, Steptoe A. Walking Speed, Cognitive Function, and Dementia Risk in the English Longitudinal Study of Ageing. J Am Geriatr Soc. 2018;66:1670–5.CrossRefPubMedPubMedCentral
26.
Handing EP, Rapp SR, Chen SH, Rejeski WJ, Wiberg M, Bandeen-Roche K, et al. Heterogeneity in Association Between Cognitive Function and Gait Speed Among Older Adults: An Integrative Data Analysis Study. J Gerontol A Biol Sci Med Sci. 2021;76:710–5.CrossRefPubMed
27.
George KM, Gilsanz P, Peterson RL, Glymour MM, Mayeda ER, Mungas DM, et al. Physical Performance and Cognition in a Diverse Cohort: Kaiser Healthy Aging and Diverse Life Experiences (KHANDLE) Study. Alzheimer Dis Assoc Disord. 2021;35:23–9.CrossRefPubMedPubMedCentral
28.
Chialà O, Vellone E, Klompstra L, Ortali GA, Strömberg A, Jaarsma T. Relationships between exercise capacity and anxiety, depression, and cognition in patients with heart failure. Heart Lung. 2018;47:465–70.CrossRefPubMed
29.
Frank CR, Xiang X, Stagg BC, JR E. Longitudinal Associations of Self-reported Vision Impairment With Symptoms of Anxiety and Depression Among Older Adults in the United States. JAMA Ophthalmol. 2019;137:793–800.CrossRefPubMedPubMedCentral
30.
Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis. CMAJ. 2012;184:E191–6.CrossRefPubMedPubMedCentral
31.
32.
Rosano C, Newman AB, Katz R, Hirsch CH, Kuller LH. Association between lower digit symbol substitution test score and slower gait and greater risk of mortality and of developing incident disability in well-functioning older adults. J Am Geriatr Soc. 2008;56:1618–25.CrossRefPubMedPubMedCentral
33.
Dong X, Li S, Sun J, Li Y, Zhang D. Association of coffee, decaffeinated coffee and caffeine intake from coffee with cognitive performance in older adults: National Health and Nutrition Examination Survey (NHANES) 2011–2014. Nutrients. 2020;12:840-56.
34.
Stevens GA, White RA, Flaxman SR, Price H, Jonas JB, Keeffe J, et al. Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990–2010. Ophthalmology. 2013;120:2377–84.CrossRefPubMed
35.
Hooyman NR, Kiyak HA. Social gerontology: A multidisciplinary perspective. Boston: Pearson Education; 2005.
36.
Tkacheva ON, Runikhina NK, Ostapenko VS, Sharashkina NV, Mkhitaryan EA, Onuchina JS, et al. Prevalence of geriatric syndromes among people aged 65 years and older at four community clinics in Moscow. Clin Interv Aging. 2018;13:251–9.CrossRefPubMedPubMedCentral
37.
Gujral S, Aizenstein H, Reynolds CF 3rd, Butters MA, Erickson KI. Exercise effects on depression: Possible neural mechanisms. Gen Hosp Psychiatry. 2017;49:2–10.CrossRefPubMedPubMedCentral
38.
Mylona I, Aletras V, Ziakas N, Tsinopoulos I. Successful Cataract Surgery Leads to an Improvement in Depressive Symptomatology. Ophthalmic Res. 2021;64:50–4.PubMed
39.
40.
Zheng DD, Swenor BK, Christ SL, West SK, Lam BL, Lee DJ. Longitudinal Associations Between Visual Impairment and Cognitive Functioning: The Salisbury Eye Evaluation Study. JAMA ophthalmology. 2018;136:989–95.CrossRefPubMedPubMedCentral
41.
Shega JW, Sunkara PD, Kotwal A, Kern DW, Henning SL, McClintock MK, et al. Measuring cognition: the Chicago Cognitive Function Measure in the National Social Life, Health and Aging Project, Wave 2. J Gerontol B Psychol Sci Soc Sci. 2014;69(Suppl 2):S166–76.CrossRefPubMedPubMedCentral
42.
Beauchet O, Launay CP, Fantino B, Allali G, Annweiler C. Respective and combined effects of impairments in sensorimotor systems and cognition on gait performance: a population-based cross-sectional study. PLoS ONE. 2015;10:e0125102.CrossRefPubMedPubMedCentral
Metadata
Title
Associations of walking impairment with visual impairment, depression, and cognitive function in U.S. older adults: NHANES 2013–2014
Authors
Wei Gao
Pengfei Dai
Yuqian Wang
Yurong Zhang
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2022
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-022-03189-y

Other articles of this Issue 1/2022

BMC Geriatrics 1/2022 Go to the issue

Research

Predictivity of the comorbidity indices for geriatric syndromes

Research

Exploring experiences and needs of spousal carers of people with behavioural variant frontotemporal dementia (bvFTD) including those with familial FTD (fFTD): a qualitative study

Research

Validity and reliability of the Thai version of the simple frailty questionnaire (T-FRAIL) with modifications to improve its diagnostic properties in the preoperative setting

Research

Effect of a multimodal non-pharmacological intervention on older people with dementia: a single-case experimental design study

Research

Internet use and physical activity of older adults during the COVID-19 pandemic: a cross-sectional study in a northern Japanese City

Research

Interaction between ω-6 fatty acids intake and blood cadmium on the risk of low cognitive performance in older adults from National Health and Nutrition Examination Survey (NHANES) 2011–2014
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits